BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 8, 2010
View Archived Issues
Swiss scientists describe novel anticancer agents
Read More
Sekmed discloses new vaccine adjuvants
Read More
Galapagos identifies novel androgen receptor ligands
Read More
SPARC staining predicts survival in rituximab-treated patients with ABC-type DLBCL
Read More
Two-year data reported on deferasirox in beta-thalassemia patients with cardiac siderosis
Read More
Quinapril and lipoic acid show benefit in metabolic syndrome
Read More
Preclinical data disclosed on discovery of novel CCK receptor antagonist JNJ-26273364
Read More
Amgen identifies novel CXCR3 antagonists for inflammatory conditions
Read More
Preclinical studies show involvement of galectin-1 in healing after acute myocardial infarction
Read More
Merck & Co. discloses new glucagon receptor antagonists
Read More
Bristol-Myers Squibb discovers new NS5B inhibitors
Read More
FDA grants fast track designation to Genta's tesetaxel for advanced gastric cancer
Read More
Lundbeck advances new agent Lu-AE-04621 to phase I for Parkinson's disease
Read More
FDA approves TachoSil surgical patch as adjunct to hemostasis in cardiovascular surgery
Read More
Allergan and Serenity Pharmaceuticals to collaborate on development Ser-120 for nocturia
Read More
Davunetide receives FDA fast track status for progressive supranuclear palsy
Read More
Bellus Health begins phase I trial of NRM-8499 for Alzheimer's disease
Read More
Living Cell Technologies' phase I/IIa Diabecell trial in type 1 diabetes meets endpoints
Read More
Recordati signs marketing agreement with Esteve for pitavastatin
Read More
Halozyme Therapeutics strengthens commercial supply agreements for rHuPH20
Read More
Multiple Myeloma Research Consortium initiates phase Ib/II Treanda trial in multiple myeloma
Read More
NeurogesX launches capsaicin patch for postherpetic neuralgia
Read More
Mologen receives funds to develop MIDGE-based DNA vaccine for hepatitis B
Read More
Phase II trial of ranibizumab in diabetic macular edema commences enrollment
Read More
MicuRx, Cumencor and Pfizer partner to develop antibiotics for multidrug-resistant tuberculosis
Read More
RXi and TransDerm form dermatology research collaboration
Read More